KMTS Stock Analysis: Buy, Sell, or Hold?
KMTS - Kestra Medical Technologies, Ltd. Common Stock
$26.99
-0.27 (-0.99%)
âŧ
5d:
-3.68%
30d:
+25.13%
90d:
+25.19%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Sep 10, 2026
16d
Get Alerted When KMTS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: KMTS is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: KMTS is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: KMTS is currently trading at $26.99, which is considered slightly high relative to its 30-day fair value range of $22.69 to $27.45.
Technical Outlook: Technically, KMTS is in a strong uptrend. The price is currently testing key support at $26.31. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: KMTS scores 27/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $30.00 (+11.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, KMTS is in a strong uptrend. The price is currently testing key support at $26.31. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: KMTS scores 27/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $30.00 (+11.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$22.69 -
$27.45
Company Quality Score
46/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
39.5%
All Signals
- BEARISH: Weak technical setup (27/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($30.00)
- WARNING: Composite score 46/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$22.69 -
$27.45
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$26.31
Resistance Level
$28.89
Current Trend
Strong Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-12.61
Wall Street Target
$30.00
(+11.2%)
Revenue Growth (YoY)
66.2%
Profit Margin
-138.3%
Share & Embed Analysis
Last updated: August 23, 2026 8:35 PM ET
Data refreshes hourly during market hours. Next update: 9:35 PM
Data refreshes hourly during market hours. Next update: 9:35 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is KMTS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Brian Daniel Webster
SELL
15000 shares
2026-04-15
Brian Daniel Webster
SELL
15000 shares
2026-03-17
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$478 | 46 HOLD |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$85 | 37 SELL |
|
WST
West Pharmaceutical ServâĻ |
STRONG BUY
13 analysts |
$405 | 66 BUY |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$186 | 45 HOLD |
|
RMD
ResMed Inc |
BUY
19 analysts |
$246 | 41 HOLD |
